Health
Putting the ‘STING’ on CAR-T cells to turn them against breast cancer and other solid tumors – FierceBiotech
Activating the immune pathway STING creates an inflammatory environment that should improve immuno-oncology treatments, but clinical trials have been disappointing…
The immune pathway known as stimulator of interferon genes (STING) has long been of interest in the oncology community because activating it creates an inflammatory environment that should improve the ability of immune cells to attack cancer. But experimental STING-activating treatments have produced mixed results in clinical trials.
Researchers at the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center have promising evidence that adding STING activators to CAR-T cell therapies…
-
Business23 hours agoHere’s my number 1 ASX passive income share
-
Noosa News17 hours agoHow cutting diplomatic ties with Tehran has affected Iranian community in Australia
-
Business22 hours agoHow to build a million-dollar ASX share portfolio in 25 years
-
General22 hours agoLabor’s socialist bedroom tax | The Spectator Australia